Ali Canbay

20.8k total citations · 8 hit papers
387 papers, 14.7k citations indexed

About

Ali Canbay is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ali Canbay has authored 387 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 228 papers in Epidemiology, 170 papers in Hepatology and 124 papers in Surgery. Recurrent topics in Ali Canbay's work include Liver Disease Diagnosis and Treatment (198 papers), Liver Disease and Transplantation (104 papers) and Organ Transplantation Techniques and Outcomes (44 papers). Ali Canbay is often cited by papers focused on Liver Disease Diagnosis and Treatment (198 papers), Liver Disease and Transplantation (104 papers) and Organ Transplantation Techniques and Outcomes (44 papers). Ali Canbay collaborates with scholars based in Germany, United States and Türkiye. Ali Canbay's co-authors include Gregory J. Gores, Guido Gerken, Ariel E. Feldstein, Lars P. Bechmann, Alexander Wree, Steven F. Bronk, Jan‐Peter Sowa, Hajime Higuchi, Hal M. Hoffman and Wing‐Kin Syn and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Ali Canbay

361 papers receiving 14.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

2003 860 citations Ali Canbay et al. profile →
NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice

2013 779 citations Ali Canbay et al. profile →
The interaction of hepatic lipid and glucose metabolism in liver diseases

2011 762 citations Lars P. Bechmann, Guido Gerken et al. profile →
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway

2004 655 citations Ali Canbay et al. profile →
From NAFLD to NASH to cirrhosis—new insights into disease mechanisms

2013 491 citations Ali Canbay et al. profile →
Extrahepatic complications of nonalcoholic fatty liver disease

2013 457 citations Ali Canbay, Wing‐Kin Syn et al. profile →
NLRP3 inflammasome activation is required for fibrosis development in NAFLD

2014 404 citations Martin Schlattjan, Ali Canbay et al. profile →
Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells

2024 47 citations Hikmet Akkız, Robert K. Gieseler et al. International Journal of Molecular Sciences profile →

Peers

Countries citing papers authored by Ali Canbay

Since Specialization

Citations

This map shows the geographic impact of Ali Canbay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Canbay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Canbay more than expected).

Fields of papers citing papers by Ali Canbay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Canbay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Canbay. The network helps show where Ali Canbay may publish in the future.

Co-authorship network of co-authors of Ali Canbay

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Canbay. A scholar is included among the top collaborators of Ali Canbay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Canbay. Ali Canbay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypertriglyceridemia Screening in Acute Pancreatitis: Diagnostic Blind Spot in Clinical Routine 2025 ·Digestive Diseases and Sciences ·(unknown), (unknown), (unknown), (unknown), Eda Kaya, (unknown), Paul Manka, Mustafa Özçürümez, (unknown), Ali Canbay, Martin Steinmetz	0
2	Hierarchy of reference interval models: advancing laboratory data interpretation 2025 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Thomas Streichert, Mustafa Özçürümez, (unknown), Ali Canbay, Abdurrahman Coşkun	0
3	Abklärung erhöhter Leberwerte 2024 ·CME ·(unknown), Mustafa Özçürümez, Ali Canbay	0
4	Religious intermittent fasting: Effects on liver health, metabolic markers, and gut microbiota in type 2 diabetes patients 2024 ·Clinical Nutrition Open Science ·Svenja Sydor, (unknown), (unknown), (unknown), Jan Best, Martin Steinmetz, (unknown), (unknown), Mustafa Özçürümez, Martina Broecker‐Preuss, Wing‐Kin Syn, Ali Canbay, Paul Manka	2
5	Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) – a multicenter, randomized, controlled, open-label investigator-initiated trial 2024 ·BMC Cancer ·(unknown), Antonia Zapf, Ann‐Kathrin Ozga, Ali Canbay, U Denzer, Enrico N. De Toni, Ansgar W. Lohse, Kornelius Schulze, Thomas Rösch, (unknown), Henning Wege, Johann von Felden	2
6	Alcohol-associated hepatitis: a neutrophile disease? 2024 ·Gut ·Maximilian Joseph Brol, Ali Canbay, Jonel Trebicka	2
7	Time-dependent characteristics of analytical measurands 2024 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Mustafa Özçürümez, Abdurrahman Coşkun, Farhad Arzideh, Thomas Streichert, (unknown), Ali Canbay, Oliver Götze, Martina Broecker‐Preuss	1
8	MASLD-Related HCC—Update on Pathogenesis and Current Treatment Options 2024 ·Journal of Personalized Medicine ·Catherine Leyh, Jason D. Coombes, Hartmut Schmidt, Ali Canbay, Paul Manka, Jan Best	15
9	Assessment of canonical diurnal variations in plasma glucose using quantile regression modelling and Chronomaps 2024 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Mustafa Özçürümez, (unknown), Abdurrahman Coşkun, Farhad Arzideh, Thomas Streichert, (unknown), Jan‐Peter Sowa, (unknown), Ali Canbay, Mario Plebani, Martina Broecker‐Preuss	1
10	Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells breakdown → 2024 ·International Journal of Molecular Sciences ·Hikmet Akkız, Robert K. Gieseler, Ali Canbay	47
11	Mechanisms and aetiology‐dependent treatment of acute liver failure 2023 ·Liver International ·(unknown), Jan‐Peter Sowa, (unknown), Pavel Strnad, Ali Canbay	8
12	Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Levels 2023 ·Journal of Personalized Medicine ·Suzan Schwertheim, (unknown), Paul Manka, Jan‐Peter Sowa, Ali Canbay, Hartmut Schmidt, Hideo A. Baba, Julia Kälsch	3
13	Whipple’s Disease – delay of diagnosis by immunosuppressive therapy; a case-series report 2023 ·Zeitschrift für Gastroenterologie ·(unknown), Armin Hoffmann, Jochen Weigt, Ali Canbay, Peter Malfertheiner, Ulrike von Arnim	1
14	A Multipathogen Bile Sample-based PCR Assay Can Guide Empirical Antimicrobial Strategies in Cholestatic Liver Diseases 2022 ·Journal of Clinical and Translational Hepatology ·Michael Jahn, Mustafa Özçürümez, Sebastian Dolff, Hana Rohn, Dominik Heider, Alexander Dechêne, Ali Canbay, Peter Rath, Antonios Katsounas	1
15	GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients 2021 ·Pharmaceuticals ·Clemens Schotten, (unknown), Jan‐Peter Sowa, Paul Manka, Lars P. Bechmann, (unknown), C. Marquardt, Marc Wichert, Hidenori Toyoda, Christian M. Lange, Ali Canbay, Philip J. Johnson, Heiner Wedemeyer, Jan Best	34
16	Incidence and Impact of Routine Inflammatory Parameters on Outcome after Transcatheter Aortic Valve Replacement 2021 ·Journal of Interventional Cardiology ·(unknown), Assem Aweimer, (unknown), (unknown), Peter Haldenwang, Justus T. Strauch, Ali Canbay, Andreas Mügge, Antonios Katsounas	4
17	Score performance of SAPS 2 and SAPS 3 in combination with biomarkers IL-6, PCT or CRP 2020 ·PLoS ONE ·Michael Jahn, Jan Rekowski, Rolf Alexander Jánosi, Andreas Kribben, Ali Canbay, Antonios Katsounas	3
18	The predictive performance of SAPS 2 and SAPS 3 in an intermediate care unit for internal medicine at a German university transplant center; A retrospective analysis 2019 ·PLoS ONE ·Michael Jahn, Jan Rekowski, Guido Gerken, Andreas Kribben, Ali Canbay, Antonios Katsounas	15
19	Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently 2014 ·Gut ·A Beilfuss, Jan‐Peter Sowa, Svenja Sydor, Mechthild Beste, Lars P. Bechmann, Martin Schlattjan, Wing‐Kin Syn, Inga Wedemeyer, Zoltán Máthé, Christoph Jochum, Guido Gerken, Robert K. Gieseler, Ali Canbay	120
20	Spontan koroner arter disseksiyonu 2007 ·Özlem Özcan Çelebi, Nermin Bayar, Ali Canbay, Savaş Çelebi, Erdem Diker, Sinan Aydoğdu	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact